Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer

Lung Cancer

Volumn 34, Issue 3, 2001, Pages 341-350

  Zhou, Jun ^a   Nong, Liang ^a   Wloch, Marek ^a   Cantor, Alan ^a   Mulshine, James L ^b   Tockman, Melvyn S ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Early detection marker; hnRNP A2 B1; Loss of heterozygosity; Microsatellite instability

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; MARKER; MESSENGER RNA; MONOCLONAL ANTIBODY; MICROSATELLITE DNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CELL CLONE; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; LUNG CANCER; LUNG NON SMALL CELL CANCER; MALE; MICROSATELLITE INSTABILITY; NORTHERN BLOTTING; PRIORITY JOURNAL; SPUTUM CYTODIAGNOSIS; BIOSYNTHESIS; CELL DIVISION; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; NONPARAMETRIC TEST; PATHOLOGY; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, NORTHERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HUMAN; LUNG NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGE; STATISTICS, NONPARAMETRIC; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 0035152574     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00254-9     Document Type: Article

References (41)

1. Purification and characterization of a protein that permits early detection of lung cancer
2. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection
3. Prospective detection of preclinical lung cancer: result from two studies of hnRNP overexpression
4. The early detection of second primary lung cancers by sputum immunostaining
5. hnRNP proteins and the biogenesis of mRNA
6. The early lung cancer marker, heterogeneous nuclear ribonucleoprotein (hnRNP) A2/B1 is an oncofetal antigen
7. Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokers
8. Causes and consequences of microsatellite instability in endometrial carcinoma
9. Loss of the PLA2G2A gene in a sporadic colorectal tumor of a patient with a PLA2G2A germline mutation and absence of PLA2G2A germline alterations in patients with FAP
10. Inactivation of the type II TGF-γ receptor in colon cancer cell with microsatellite instability
11. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype
12. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability
13. Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene
14. Differences in patterns of TP53 and KRAS2 mutations in a large series of endometrial carcinomas with or without microsatellite instability
15. Alteration of the PPP2R1B gene in human lung and colon cancer
16. Identification of three distinct tumor suppressor loci on the short arm chromosome 9 in small cell lung cancer
17. Frequent microsatellite instability in primary small cell lung cancer
18. Microsatellite instablity at AAAG repeat sequences in respiratory tract cancers
19. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma
20. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 oral premalignant lesions and their value in cancer risk assessment
21. Clonal genetic alterations in the lung's of current and former smokers
22. Microsatellite instability analysis: a multicenter study for reliability and quality control
23. Multiple head and neck tumors: evidence for a common clonal origin
24. Allootype and replication error phenotype of small cell lung carcinoma
25. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers
26. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer
27. Fractional allele loss data indicate distinct genetic populations in the development of non-small-cell lung cancer
28. 'Field cancerization' in oral stratified squamous epithelium
29. Expression of early lung cancer detection marker p31 in neoplastic and non-neoplastic respiratory epithelium
30. Sequential loss of heterozygosity in the progression of squamous cell carcinoma of the lung
31. Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: a clinical marker of early lung cancer detection
32. Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers
33. Microsatellite alterations in bronchial and sputum specimens of lung cancer patients
34. Microsatellite instability and loss of heterozygosity at chromosomes 9 and 17 in non-small cell lung cancer
35. Loss of heterozygosity at 3p in non-small cell lung cancer and it's implication
36. Phenotypically different cells with heterogeneous nuclear ribonucleoprotein A2/B1 overexpression show similar genetic alterations
37. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis in cell cycle control
38. Infrequent mutations of the transforming growth factor beta-type II receptor gene at chromosome 3p22 in human lung cancers with chromosome 3p deletions
39. Molecular characterization of the hnRNP-A2/B1 proteins: tissue-expression and novel isoforms